60 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
26 Mar 24
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
7:12am
in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative disorders of the central nervous system
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
are a part.
Company Overview
We are a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule … biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative … in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system
8-K
EX-99.1
8kjoy
4 Jan 24
Other Events
4:21pm
8-K
EX-99.1
9it3vb0xth237f8h7gt
2 Nov 23
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
nxdiy kedlxe
12 Sep 23
Other Events
7:00am
8-K
EX-99.1
kjy82h
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
5i8dy8v a7r14s3
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
ns55tinn3wqcww87pjz
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
EX-99.1
1elogwskyz3hchf
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
S-3
f6d9htaje0 gikryq
23 Dec 22
Shelf registration
4:16pm
8-K
EX-99.1
g30b1k8 nmd2
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.2
93mmnh5ixvi p9
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am